Pernix Therapeutics Appoints Ken Piña as General Counsel and Chief Compliance Officer
Jan 06, 2017 21:01 pm UTC| Business
MORRISTOWN, N.J., Jan. 06, 2017 -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company with a focus on pain and CNS conditions, today announced the appointment of KenPiñaas Senior Vice...
Jan 06, 2017 21:01 pm UTC| Business
BASKING RIDGE, N.J., Jan. 06, 2017 -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a cell therapy company combining a select therapeutic development pipeline with an industry-leading...
Kratos to Present at the 19th Annual Needham Growth Conference
Jan 06, 2017 21:00 pm UTC| Business
SAN DIEGO, Jan. 06, 2017 -- Kratos Defense Security Solutions, Inc. (NASDAQ:KTOS), a leading National Security Solutions provider, today announced that its President CEO, Eric DeMarco, and its Executive VP CFO,...
Ardea Resources Limited Project Update
Jan 06, 2017 20:29 pm UTC| Business
Sydney, Australia, Jan. 06, 2017 -- KNP pyrolusitic ore. This drill...
Live Ventures CEO, Jon Isaac, Purchases More Than $250,000 in Company Stock in the Open Market
Jan 06, 2017 20:15 pm UTC| Business
LAS VEGAS, Jan. 06, 2017 -- Live Ventures Incorporated (Nasdaq:LIVE) (“Live Ventures” or the “Company”), a diversified holding company, announces today that company CEO, Jon Isaac, has purchased more than $250,000 in...
Genmab Achieves USD 25 Million Sales Milestone in DARZALEX® (daratumumab) Collaboration with Janssen
Jan 06, 2017 20:13 pm UTC| Business
Company Announcement First sales volume milestone reached in DARZALEX (daratumumab) collaboration with Janssen Genmab to receive milestone payment of USD 25 million Copenhagen, Denmark; January 6, 2017 –...
Jan 06, 2017 20:01 pm UTC| Business
NEW YORK, Jan. 06, 2017 -- The following statement is being issued by Levi Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired shares of Inotek Pharmaceuticals Corporation (“Inotek”)...